Arvinas (ARVN) EBT Margin Growth (3y) (2020 - 2026)
Arvinas (ARVN) EBT Margin Growth (3y) (2020 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | 9,237.00 |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | 441.00 |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | -408.00 |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | 363.00 |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | - |
| 10 | Arvinas | 529.92 Mn | -84.98 Mn | - | -11,874.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -11,874.00 |
| Dec 31, 2025 | -52,404.00 |
| Sep 30, 2025 | 10,098.00 |
| Jun 30, 2025 | -8,491.00 |
| Mar 31, 2025 | 25,760.00 |
| Dec 31, 2024 | 6,200.00 |
| Sep 30, 2024 | 45,576.00 |
| Jun 30, 2024 | 86,879.00 |
| Mar 31, 2024 | 47,154.00 |
| Dec 31, 2023 | 98,200.00 |
| Sep 30, 2023 | 25,474.00 |
| Jun 30, 2023 | 37,034.00 |
| Mar 31, 2023 | 12,217.00 |
| Dec 31, 2022 | 25,897.00 |
| Sep 30, 2022 | -19,751.00 |
| Jun 30, 2022 | 24,747.00 |
| Mar 31, 2022 | 15,283.00 |
| Dec 31, 2021 | 31,961.00 |
| Sep 30, 2021 | -10,659.00 |
| Jun 30, 2021 | -67,960.00 |